Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells

A Retraction to this article was published on 16 June 2011

Abstract

The molecular mechanism of striking higher prevalence of hepatocellular carcinoma (HCC) in male subjects has not yet been fully elucidated. Here, we report that androgen receptor (AR) is differentially expressed in different HCC cell lines. AR agonist dihydrotestosterone (DHT) enhances HCC cell growth and apoptotic resistance. Antagonist flutamide (FLU) blocks the effects of DHT on the HCC cell lines. Paternally expressed gene 10 (PEG10) is expressed in HCC cell lines at substantial high level. Using small interfering RNAs against AR and PEG10 in AR- and PEG10-expressing BEL-7404 hepatoma cells and HuH7 hepatoma cells (HuH7) cells, and AR-transfection technique in AR-lacking and PEG10-expressing HepG2 cells, we have confirmed that through upregulation and activation of PEG10, DHT enhances HCC cell growth and apoptotic resistance. We have further demonstrated that DHT upregulates expression of human telomerase reverse transcriptase (hTERT) in HCC cell lines in a PEG10-dependent manner. Moreover, AR directly interacts in vivo with androgen-responsive elements in the regions of promoter and exon 2 of PEG10 gene in HCC cell lines. DHT promotes the hepatoma formation in vivo nude mice through PEG10 activation. AR antagonists (FLU and valproate) inhibit the hepatoma formation. These findings suggest that PEG10 plays an essential role in hepatocarcinogenesis. The PEG10 inhibition can be a novel approach for therapy of HCC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Chunsong H, Yuling H, Li W, Jie X, Gang Z, Qiuping Z et al. (2006). CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic Leukemia CD23+CD5+ B Cells. J Immunol 177: 6713–6722.

    Article  PubMed  Google Scholar 

  • Death AK, McGrath KC, Handelsman DJ . (2005). Valproate is an anti-androgen and anti-progestin. Steroids 70: 946–953.

    Article  CAS  PubMed  Google Scholar 

  • Greider CW . (1999). Telomerase activation: one-step on the road to cancer? Trends Genet 15: 109–112.

    Article  CAS  PubMed  Google Scholar 

  • Huang R, Xing Z, Luan Z, Wu T, Wu X, Hu G . (2003). A specific splicing variant of SVH, a novel human armadillo repeat protein, is up-regulated in hepatocellular carcinomas. Cancer Res 63: 3775–3782.

    CAS  PubMed  Google Scholar 

  • Jinquan T, Jacobi HH, Jing C, Millner A, Sten E, Hviid L et al. (2003). CCR3 expression induced by IL-2 and IL-4 functioning as a death receptor for B cells. J Immunol 171: 1722–1731.

    Article  PubMed  Google Scholar 

  • Kim DH, Behlke MA, Rose SD, Chang MS, Choi S, Rossi JJ . (2005). Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol 23: 222–226.

    Article  CAS  PubMed  Google Scholar 

  • Komine F, Shimojima M, Moriyama M, Amaki S, Uchida T, Arakawa Y . (2000). Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgment of efficacy of treatment of small hepatocellular carcinoma. J Hepatol 132: 235–241.

    Article  Google Scholar 

  • Li CM, Margolin AA, Salas M, Memeo L, Mansukhani M, Hibshoosh H et al. (2006). PEG10 is a c-MYC target gene in cancer cells. Cancer Res 66: 665–672.

    Article  CAS  PubMed  Google Scholar 

  • Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP . (2001). Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276: 13442–13451.

    Article  CAS  PubMed  Google Scholar 

  • Massari P, Ho Y, Wetzler LM . (2000). Neisseria meningitidis porin PorB interacts with mitochondria and protects cells from apoptosis. Proc Natl Acad Sci USA 97: 9070–9075.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nagasue N, Yu L, Yukaya H, Kohno H, Nakamura T . (1995). Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br J Surg 82: 542–547.

    Article  CAS  PubMed  Google Scholar 

  • Okabe H, Satoh S, Furukawa Y, Kato T, Hasegawa S, Nakajima Y et al. (2003). Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res 63: 3043–3048.

    CAS  PubMed  Google Scholar 

  • Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y et al. (2001). Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61: 2129–2137.

    CAS  PubMed  Google Scholar 

  • Ono R, Kobayashi S, Wagatsuma H, Aisaka K, Kohda T, Kaneko-Ishino T et al. (2001). A retrotransposon-derived gene, peg10, is a novel imprinted gene located on human chromosome 7q21. Genomics 73: 232–237.

    Article  CAS  PubMed  Google Scholar 

  • Ono R, Nakamura K, Inoue K, Naruse M, Usami T, Wakisaka-Saito N et al. (2006). Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality. Nat Genet 38: 101–106.

    Article  CAS  PubMed  Google Scholar 

  • Ramirez R, Carracedo J, Jimenez R, Canela A, Herrera E, Aljama P et al. (2003). Massive telomere loss is an early event of DNA damaged-induced apoptosis. J Biol Chem 278: 836–842.

    Article  CAS  PubMed  Google Scholar 

  • Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Chumakov PM, Kravchenko JE et al. (2005). Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. Oncogene 24: 6773–6784.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sathya G, Chang CY, Kazmin D, Cook CE, McDonnell DP . (2003). Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion. Cancer Res 63: 8029–8036.

    CAS  PubMed  Google Scholar 

  • Shammas MA, Koley H, Batchu RB, Bertheau RC, Protopopov A, Munshi NC et al. (2005). Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 4: 24–37.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sica A, Saccani A, Borsatti A, Power CA, Wells TN, Luini W et al. (1997). Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 185: 969–974.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Steplewski A, Krynska B, Tretiakova A, Haas S, Khalili K, Amini S . (1998). MyEF-3, a developmentally controlled brain-derived nuclear protein which specifically interacts with myelin basic protein proximal regulatory sequences. Biochem Biophys Res Commun 243: 295–301.

    Article  CAS  PubMed  Google Scholar 

  • Tsou AP, Chuang YC, Su JY, Yang CW, Liao YL, Liu WK et al. (2003). Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. J Biomed Sci 10: 625–635.

    CAS  PubMed  Google Scholar 

  • Youssef N, Paradis V, Ferlicot S, Bedossa P . (2001). In situ detection of telomerase enzymatic activity in human hepatocellular careinogenesis. J Pathol 194: 459–465.

    Article  CAS  PubMed  Google Scholar 

  • Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM et al. (2001). Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 93: 1644–1651.

    Article  CAS  PubMed  Google Scholar 

  • Zhang DY, Sabla G, Shivakumar P, Tiao G, Sokol RJ, Mack C et al. (2004). Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology 39: 954–962.

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Wang XW, Jelovac D, Nakanishi T, Yu MH, Akinmade D et al. (2005). The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proc Natl Acad Sci USA 102: 9890–9895.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by National Natural Science Foundation of China (no. 39870674, 30572119, 30030130, 30471509, 30670937). Dr Tan Jinquan is a Chang Jiang Scholar supported by Chang Jiang Scholars Program from Ministry of Education, China and Li Ka Shing Foundation, Hong Kong, China.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to J Youxin or T Jinquan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jie, X., Lang, C., Jian, Q. et al. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene 26, 5741–5751 (2007). https://doi.org/10.1038/sj.onc.1210362

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210362

Keywords

This article is cited by

Search

Quick links